Table 1.
Table. Compiled Results of Observational and Behavioral Studies Associating Maternal Antibodies With Autisma
Antibody Target | MW | Prevalence, % | Maternal IgG Population, No. |
---|---|---|---|
Observational Studies | |||
Child/paternal lymphocytes25 | Undetermined | 54 (against child’s or father’s cells) | AU = 11; TD = 20 |
Rat fetal/juvenile/adult brain26 | Multiple low MW and 250 kDa | 100 (2 patterns) | AU = 11; TD = 10 |
Human fetal brain27 | 37 kDa and 73 kDa pair | 12 | AU = 61; DD = 40; TD = 62 |
Human fetal brain28 | 39 kDa and 39 kDa/73 kDa pair | 7 (for 39 kDa) | AU = 84; DD = 49; TD = 160 |
Fetal/adult human and rat brain29 | 36 kDa, 39 kDa, and 61 kDa | 10 (36 kDa for human fetal brain) | AU = 100; TD = 100 |
Fetal rhesus macaque brain30 | 37 kDa/73 kDa and 39 kDa/73 kDa pairs | 7 (37/73 kDa) and 4 (39/73 kDa) | AU = 201; ASD = 71; TD = 185; DD = 102 |
Species | Significant Outcomes | Administration Route; Gestational Age; Amount per Injection; Serum or IgG | Maternal IgG Population |
---|---|---|---|
Animal Behavioral Studies | |||
Rat31 | Decreased exploration Impaired motor control IHC Purkinje/neuroblastoma staining Decreased choline and creatinine levels |
Intraperitoneal; embryonic day (for rodents) 10–17; 0.5 mL; serum | AU = 1; TD = 4 (all multiplex) |
Rhesus macaque32 | Reduced peer contact Increased nonsocial activity Hyperactivity Whole-body stereotypies |
Intravenous; gestational day (for primates) 27, 41, and 55; 15–20 mg; IgG | AU = 12; TD = 7 (all multiplex) |
Mouse24 | Hyperactivity Increased anxiety Reduced social interaction Embryonic day 18 microglial activation Increased brain BDNF levels |
Intraperitoneal; embryonic day 13–18; 1.25–1.4 mg; IgG | AU = 63; TD = 63 (mixed parity) |
Abbreviations: ASD, autism spectrum disorder; AU, autism; BDNF, brain-derived neurotrophic factor; DD, developmental delay (nonautism); MW, molecular weight; TD, typically developing.
Observational studies of maternal antibody binding to fetal brain proteins have often noted maternal IgG reactivity to antigens of approximately 36 to 39 kDa, focusing candidate protein identification on this MW range. Behavioral studies have recapitulated some of the features of autism in model systems and have yielded substantially consistent results.